Fast Five Quiz: Assessment of Tardive Dyskinesia

Christoph U. Correll, MD


January 19, 2022

The AIMS is recommended in patients who are receiving treatment with substances that may cause TD, such as antipsychotics. According to the American Psychiatric Association guidelines, it should be administered at baseline before the institution of pharmacotherapy to document any movements present, and then at every visit during the course of treatment.

Learn about the assessment of patients with schizophrenia.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.